US stocks lose faith in the Trump bump

US stocks hit new records in March, but have drifted downwards since then as more and more investors have decided that Trump looks both capricious and ineffectual.

Ralph Waldo Emerson said that "a foolish consistency is the hobgoblin of little minds". Donald Trump "is proving to be anything but small-minded", says Randall Forsyth in Barron's. He has produced "several head-snapping reversals" of previous positions. China is apparently no longer a currency manipulator. Janet Yellen may, after all, get another term at the US Federal Reserve. After decrying US overseas adventures, he has waded into Syria and is threatening North Korea.

As far as markets are concerned, says Larry Elliott in The Guardian, the impression is that Trump is "dangerously unpredictable". It's pretty clear now that "he is making it up as he goes along". The failure to replace Obamacare "was the first sign of trouble", since it cast doubt on the White House's economic stimulus package. History shows that "even the most effective presidents barely get through Congress half of what they campaigned on", notes David Rosenberg of Gluskin Sheff.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.